Syngene Boosts Biologics Manufacturing Capability Following Impressive Q1 Performance
Syngene International Limited has demonstrated a stellar start to the fiscal year with a 26% YoY surge in both revenues and profit after tax. This strong Q1 performance sets the stage for the company’s strategic expansion plans. In a significant…
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high speed, commercial scale, fill-finish unit
Syngene today announced the acquisition of Unit 3 biologics manufacturing facility in Bangalore, India, from Stelis Biopharma Limited (SBL). The companies have entered into a binding term sheet and, on completion of the transaction, the site will add 20,000 liters…
14-year-old Ethiopian boy undergoes complex kidney transplantation surgery at Aster CMI Hospital
A 14-year-old boy from Ethiopia with stunted growth and bony deformities was given a new lease of life by his father as a kidney donor at Aster CMI Hospital, Bangalore. The child was diagnosed with a condition called posterior urethral…
Nasal Vaccines – What you need to know
The author of this article is Dr. Swati Rajagopal, Consultant – Infectious Disease & Travel Medicine, Aster CMI Hospital, Bangalore As the world once again braces itself for the new wave of Covid-19 virus, nasal vaccines have now offered a…
Long-term implications of arthritis if left untreated
The author of this article is Dr. Chethana D, Consultant – Rheumatology, Aster CMI Hospital, Bangalore Rheumatoid Arthritis (RA) is a chronic inflammatory disease wherein your immune system mistakenly attacks healthy tissues of the body causing inflammation. In RA, joints…
Merck India inaugurates its
R&D Excellence Centre in Bangalore
Bangalore, India: Merck, a leading science & technology company in the business of healthcare, life science & electronics, today announced the inauguration of its Healthcare R&D Excellence Centre facility in Bangalore. The Merck India R&D Excellence Centre contributes to the…
Bangalore based health-tech startup Clinikk expands footprints into newer markets
Clinikk, a Bengaluru based health-tech start-up launches its path breaking, all-inclusive health subscriptions that will bring down medical cost to zero by integrating health insurance with its high-quality, comprehensive outpatient care delivery model. Clinikk is on a mission to transform…
